Literature DB >> 18986392

Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients.

Andrea Balreira, Maria F Macedo, Cristina Girão, Lorena G Rodrigues, João P Oliveira, Maria Clara Sá Miranda, Fernando A Arosa.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18986392     DOI: 10.1111/j.1365-2141.2008.07380.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

1.  Innate and Adaptive Immune Response in Fabry Disease.

Authors:  Wladimir Mauhin; Olivier Lidove; Elisa Masat; Federico Mingozzi; Kuberaka Mariampillai; Jean-Marc Ziza; Olivier Benveniste
Journal:  JIMD Rep       Date:  2015-02-18

Review 2.  CD1-Restricted T Cells at the Crossroad of Innate and Adaptive Immunity.

Authors:  Catia S Pereira; M Fatima Macedo
Journal:  J Immunol Res       Date:  2016-12-14       Impact factor: 4.818

Review 3.  From Lysosomal Storage Diseases to NKT Cell Activation and Back.

Authors:  Cátia S Pereira; Helena Ribeiro; M Fatima Macedo
Journal:  Int J Mol Sci       Date:  2017-02-25       Impact factor: 5.923

4.  Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.

Authors:  Anneliese O Speak; Nicholas Platt; Mariolina Salio; Danielle te Vruchte; David A Smith; Dawn Shepherd; Natacha Veerapen; Gurdyal S Besra; Nicole M Yanjanin; Louise Simmons; Jackie Imrie; James E Wraith; Robin H Lachmann; Ralf Hartung; Heiko Runz; Eugen Mengel; Michael Beck; Christian J Hendriksz; Forbes D Porter; Vincenzo Cerundolo; Frances M Platt
Journal:  Eur J Immunol       Date:  2012-06-14       Impact factor: 5.532

5.  Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition.

Authors:  Crina Paduraru; Jelena S Bezbradica; Amit Kunte; Robert Kelly; James A Shayman; Natacha Veerapen; Liam R Cox; Gurdyal S Besra; Peter Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.